These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32985411)

  • 1. Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis.
    Nakamura D; Dohi T; Ishihara T; Kikuchi A; Mori N; Yokoi K; Shiraki T; Mizote I; Mano T; Higuchi Y; Yamada T; Nishino M; Sakata Y
    EuroIntervention; 2021 Aug; 17(6):489-496. PubMed ID: 32985411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
    Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Fall K; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1115-1124. PubMed ID: 28281026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between asymmetric dimethylarginine and in-stent restenosis tissue characteristics assessed by optical coherence tomography.
    Huang WC; Teng HI; Chen HY; Wu CJ; Tsai CT; Hsueh CH; Chen YY; Hau WK; Lu TM
    Int J Cardiol; 2019 Aug; 289():131-137. PubMed ID: 31079970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Neoatherosclerosis Patterns in Drug-Eluting- and Bare-Metal Stent Restenosis　- Optical Coherence Tomography Study.
    Nakamura D; Yasumura K; Nakamura H; Matsuhiro Y; Yasumoto K; Tanaka A; Matsunaga-Lee Y; Yano M; Yamato M; Egami Y; Shutta R; Sakata Y; Tanouchi J; Nishino M
    Circ J; 2019 Jan; 83(2):313-319. PubMed ID: 30487370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-target lesion progression: Unveiling critical predictors and outcomes in patients with in-stent restenosis.
    Zhang W; Zhang W; Deng Y; Gu N; Qiu Z; Deng C; Yang S; Pan L; Long S; Wang Y; Zhao Y; Shi B
    Int J Cardiol; 2024 Dec; 416():132451. PubMed ID: 39147280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.
    Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
    Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
    JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Predictors of Neoatherosclerosis in Patients with Early In-Stent Restenosis Determined Using Optical Coherence Tomography.
    Meng L; Liu X; Yu H; Wei G; Gu X; Chang X; Xie M; Qu W; Peng X; Sun Y; Tian J; Yu B
    Int Heart J; 2020 Sep; 61(5):872-878. PubMed ID: 32921669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
    Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
    EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [OCT analysis of in-stent neointima over 5 years post-DES implantation].
    Han Y; Yuan XH; Jiang MT; Feng HH; Zhang X; Zhang YQ; Jing J; Chen YD; Gao L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Feb; 52(2):150-157. PubMed ID: 38326066
    [No Abstract]   [Full Text] [Related]  

  • 14. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
    Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
    [No Abstract]   [Full Text] [Related]  

  • 17. Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis.
    Nano N; Aytekin A; Ndrepepa G; Seguchi M; Bresha J; Alvarez Covarrubias HA; Nicol P; Lenz T; Lahu S; Gewalt S; Voll F; Rheude T; Wiebe J; Schunkert H; Kufner S; Cassese S; Joner M; Kastrati A; Xhepa E
    Clin Res Cardiol; 2022 Jul; 111(7):827-837. PubMed ID: 35476138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular Ultrasound and Angiographic Predictors of In-Stent Restenosis of Chronic Total Occlusion Lesions.
    Kang J; Cho YS; Kim SW; Park JJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Youn TJ; Chae IH; Choi DJ
    PLoS One; 2015; 10(10):e0140421. PubMed ID: 26465755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, Management and Outcomes of Percutaneous Coronary Intervention for Coronary In-Stent Restenosis: Insights From the France PCI Registry.
    Duband B; Souteyrand G; Clerc JM; Chassaing S; Fichaux O; Marcollet P; Deballon R; Roussel L; Pereira B; Collet JP; Commeau P; Cayla G; Koning R; Motreff P; Benamer H; Rangé G
    Cardiovasc Revasc Med; 2023 Jul; 52():39-46. PubMed ID: 36813696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.